Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G J Nemo

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Annals of Internal Medicine|July 4, 2001
Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV diseaseE L Murphy, A C Collier, L A Kalish, et al.
Transfusion|September 1, 1989
Prevalence of antibodies to human immunodeficiency virus type 1 among blood donors prior to screening. The Transfusion Safety Study/NHLBI Donor RepositoryS H Kleinman, J C Niland, S P Azen, et al.
JAMA|April 3, 1996
Demographic determinants of hepatitis C virus seroprevalence among blood donorsE L Murphy, S Bryzman, A E Williams, et al.
The New England Journal of Medicine|August 5, 1999
Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 TeamL M Mofenson, J S Lambert, E R Stiehm, et al.
The Journal of Infectious Diseases|December 12, 1997
Increased prevalence of infectious diseases and other adverse outcomes in human T lymphotropic virus types I- and II-infected blood donors. Retrovirus Epidemiology Donor Study (REDS) Study GroupE L Murphy, S A Glynn, J Fridey, et al.
Hepatology (Baltimore, Md.)|March 8, 2000
Risk factors for hepatitis C virus infection in United States blood donors. NHLBI Retrovirus Epidemiology Donor Study (REDS)E L Murphy, S M Bryzman, S A Glynn, et al.
Transfusion|September 30, 1999
Absence of human T-lymphotropic virus type I tax sequences in a population of normal blood donors in the Baltimore, MD/Washington, DC, area: results from a multicenter studyE P Cowan, G J Nemo, A E Williams, et al.
Transfusion|July 1, 2005
The RADAR repository: a resource for studies of infectious agents and their transmissibility by transfusionS H Kleinman, S A Glynn, M J Higgins, et al.
The Journal of Infectious Diseases|February 1, 1997
Safety and pharmacokinetics of hyperimmune anti-human immunodeficiency virus (HIV) immunoglobulin administered to HIV-infected pregnant women and their newborns. Pediatric AIDS Clinical Trials Group Protocol 185 Pharmacokinetic Study GroupJ S Lambert, L M Mofenson, C V Fletcher, et al.
Transfusion|August 16, 2003
Multicenter comparison of serologic assays and estimation of human herpesvirus 8 seroprevalence among US blood donorsP E Pellett, D J Wright, E A Engels, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Annals of Internal Medicine|July 4, 2001
Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV diseaseE L Murphy, A C Collier, L A Kalish, et al.
Transfusion|September 1, 1989
Prevalence of antibodies to human immunodeficiency virus type 1 among blood donors prior to screening. The Transfusion Safety Study/NHLBI Donor RepositoryS H Kleinman, J C Niland, S P Azen, et al.
JAMA|April 3, 1996
Demographic determinants of hepatitis C virus seroprevalence among blood donorsE L Murphy, S Bryzman, A E Williams, et al.
The New England Journal of Medicine|August 5, 1999
Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 TeamL M Mofenson, J S Lambert, E R Stiehm, et al.
The Journal of Infectious Diseases|December 12, 1997
Increased prevalence of infectious diseases and other adverse outcomes in human T lymphotropic virus types I- and II-infected blood donors. Retrovirus Epidemiology Donor Study (REDS) Study GroupE L Murphy, S A Glynn, J Fridey, et al.
Hepatology (Baltimore, Md.)|March 8, 2000
Risk factors for hepatitis C virus infection in United States blood donors. NHLBI Retrovirus Epidemiology Donor Study (REDS)E L Murphy, S M Bryzman, S A Glynn, et al.
Transfusion|September 30, 1999
Absence of human T-lymphotropic virus type I tax sequences in a population of normal blood donors in the Baltimore, MD/Washington, DC, area: results from a multicenter studyE P Cowan, G J Nemo, A E Williams, et al.
Transfusion|July 1, 2005
The RADAR repository: a resource for studies of infectious agents and their transmissibility by transfusionS H Kleinman, S A Glynn, M J Higgins, et al.
The Journal of Infectious Diseases|February 1, 1997
Safety and pharmacokinetics of hyperimmune anti-human immunodeficiency virus (HIV) immunoglobulin administered to HIV-infected pregnant women and their newborns. Pediatric AIDS Clinical Trials Group Protocol 185 Pharmacokinetic Study GroupJ S Lambert, L M Mofenson, C V Fletcher, et al.
Transfusion|August 16, 2003
Multicenter comparison of serologic assays and estimation of human herpesvirus 8 seroprevalence among US blood donorsP E Pellett, D J Wright, E A Engels, et al.
Pageof 4